Home > Alios Biopharma Salary

Alios Biopharma Salary

  • 93
  • 30
  • 16
Alios Biopharma average salary is $100,000, median salary is $100,000 with a salary range from $100,000 to $100,000.
Alios Biopharma salaries are collected from government agencies and companies. Each salary is associated with a real job position. Alios Biopharma salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 1 Alios Biopharma Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Senior Software Engineer 100,000-100,000 Sunnyvale, CA, 94086 2013 Alios Biopharma Senior Software Engineer Salaries (1)
Alios Biopharma Sunnyvale, CA Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Alios Biopharma salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Alios Biopharma Jobs
See more Alios Biopharma Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Alios Biopharma... Information
  • Alios BioPharma Inc
  • Industry: BioTech/Drugs
  • City: South San Francisco, CA
  • Alios is discovering and developing novel therapeutic agents based on three platform technologies including: small molecule activators of innate immunity antiviral pathways (RNase L activation), phosphate protected nucleotide prodrug chemistry, and glycoprotein-engineering of interferons (Glycoferona). This complementary group of platform technologies has the potential to generate a number of distinct therapeutic products to treat a variety of serious viral infections such as chronic hepatitis B and C, HIV infection, and respiratory viruses (e.g. pandemic influenza) and emerging viral diseases (e.g. SARS).